Skip to content

Use of BIP-Needles in Rheumatologic Injections

INJ-INAR-01 Use of BIP-Needles in Rheumatologic Injections

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02605928
Enrollment
79
Registered
2015-11-17
Start date
2014-10-31
Completion date
2016-01-31
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra-articular Injections

Keywords

Arthritis, Bioimpedance, Glucocorticoid, Intra-articular injection, Needle Guidance

Brief summary

The study focuses on needle guidance in rheumatologic operations - glucocorticoid injections inside joint capsules specifically. The main purpose of the study is to assess and validate the clinical feasibility and performance of Bioimpedance Probe (BIP) Needles and assess the benefits, drawbacks and risks related to use of the BIP Needles.

Detailed description

Clinical device investigation

Interventions

Injeq Bioimpedance Probe (BIP) Needle is an injection needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with synovial fluid.

Sponsors

Injeq Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patients having an inflammatory rheumatic disease requiring an intra-articular glucocorticoid injection.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
True Positive Detection of Synovial Fluid Marked in Case Report FormDuring intra-articular injectionMeasurement device indicates with a sound and visual feedback when needle is in contact with synovial fluid. Physician verifies the location with ultrasound imaging, aspiration of synovial fluid and/or lack of resistance in glucocorticoid injection. Even if the device does not detect the synovial fluid, physician performs the injection when needed. Physician marks to the case report form whether the device provided detections during the puncture and were the detections true or false detections.

Countries

Finland

Participant flow

Recruitment details

First punctures were utilized for tissue detection model validation and tuning. In pivotal phase, the model kept unchanged. Performance of the device was evaluated from pivotal phase results.

Participants by arm

ArmCount
BIP Needle
Injeq Bioimpedance Probe (BIP) Needle is an injection needle that has bioimpedance measurement capability. It measures bioimpedance and detects synovial fluid during inta-articular injection. Injeq Bioimpedance Probe (BIP) Needle: Injeq Bioimpedance Probe (BIP) Needle is an injection needle that has bioimpedance measurement capability. It consists of traditional needle cannulae and removable bioimpedance probe which enables the measurement of bioimpedance. The needle is connected to measurement device and tissue identifying algorithm. Bioimpedance is measured during the operation and the algorithm detects when the needle tip is in contact with synovial fluid.
79
Total79

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLack of Efficacy5
Overall StudyModel tuning phase28

Baseline characteristics

CharacteristicBIP Needle
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
21 Participants
Age, Categorical
Between 18 and 65 years
58 Participants
Age, Continuous51 years
Sex: Female, Male
Female
63 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 79
serious
Total, serious adverse events
0 / 79

Outcome results

Primary

True Positive Detection of Synovial Fluid Marked in Case Report Form

Measurement device indicates with a sound and visual feedback when needle is in contact with synovial fluid. Physician verifies the location with ultrasound imaging, aspiration of synovial fluid and/or lack of resistance in glucocorticoid injection. Even if the device does not detect the synovial fluid, physician performs the injection when needed. Physician marks to the case report form whether the device provided detections during the puncture and were the detections true or false detections.

Time frame: During intra-articular injection

ArmMeasureValue (NUMBER)
BIP NeedleTrue Positive Detection of Synovial Fluid Marked in Case Report Form86 percentage of injected joints

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026